News
An interaction between two proteins points to a molecular basis for memory. But how do memories last when the molecules that ...
Scientists have developed a technique that aligns stem cells into a single sheet, resulting in a marked increase in the secretion of signaling proteins which help repair tissue and regulate the immune ...
A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...
A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the parasite responsible for the deadliest form of human malaria, that could ...
Citrate is essential for the metabolism and development of neurons. A membrane transport protein called SLC13A5 plays a ...
Levels of protein structure Proteins are large molecules formed from condensation reactions between amino acids. They have complex shapes that allow them to facilitate various reactions in living ...
We explored the structure change of adversarial protein sequences predicted by AF2 compared to the wild type protein’s structure. CASP14 experiments indicated that altering only three residues via ...
MULTICOM4 is an advanced protein structure prediction system built on AlphaFold2 and 3. It achieved remarkable success in the 16th world-wide Critical Assessment of Techniques for Protein Structure ...
Symmetry is a common theme in protein tertiary structure. The gene duplication and fusion hypothesis provides an evolutionary framework for the emergence of symmetric protein architectures from ...
Building on the transformer architecture and its revolutionizing of language models for natural language processing, protein language models (PLMs) are now emerging as a powerful tool for learning ...
The tertiary structure of proteins is such that it is suited to the function of the protein. Proteins function in different environments, and thus each protein has different requirements.
Ribosomal protein S26 (RPS26) expression of advanced cervical cancer (CC) to predict response to programmed death-1 inhibitor combination therapy: A secondary analysis of the CIBI308ALTER-C201 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results